Your browser is no longer supported. Please, upgrade your browser.
Settings
RGEN Repligen Corporation daily Stock Chart
RGEN [NASD]
Repligen Corporation
Index- P/E86.57 EPS (ttm)0.51 Insider Own11.70% Shs Outstand42.34M Perf Week2.36%
Market Cap1.87B Forward P/E59.91 EPS next Y0.74 Insider Trans-0.42% Shs Float38.71M Perf Month5.27%
Income17.70M PEG3.46 EPS next Q0.11 Inst Own85.70% Short Float7.60% Perf Quarter10.13%
Sales113.30M P/S16.50 EPS this Y23.10% Inst Trans11.48% Short Ratio8.37 Perf Half Y27.20%
Book/sh5.60 P/B7.88 EPS next Y24.49% ROA6.00% Target Price46.80 Perf Year32.11%
Cash/sh3.42 P/C12.90 EPS next 5Y25.00% ROE10.10% 52W Range26.16 - 46.81 Perf YTD43.25%
Dividend- P/FCF- EPS past 5Y53.60% ROI6.00% 52W High-5.68% Beta1.22
Dividend %- Quick Ratio10.30 Sales past 5Y34.80% Gross Margin54.70% 52W Low68.77% ATR1.11
Employees236 Current Ratio11.90 Sales Q/Q11.30% Oper. Margin15.80% RSI (14)56.43 Volatility3.24% 2.39%
OptionableYes Debt/Eq0.51 EPS Q/Q112.20% Profit Margin15.60% Rel Volume0.40 Prev Close44.21
ShortableYes LT Debt/Eq0.51 EarningsAug 03 BMO Payout0.00% Avg Volume351.20K Price44.15
Recom1.80 SMA202.30% SMA504.62% SMA20020.52% Volume141,808 Change-0.14%
Jul-21-17Initiated William Blair Outperform
Feb-13-17Upgrade Piper Jaffray Neutral → Overweight
Feb-22-16Initiated Craig Hallum Buy
Nov-06-15Downgrade Jefferies Buy → Hold
Apr-23-15Reiterated Jefferies Buy $25 → $38
Mar-07-11Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
Jun-30-09Initiated Merriman Buy
Jun-12-08Reiterated Rodman & Renshaw Mkt Outperform $11 → $9
Sep-10-07Reiterated Rodman & Renshaw Mkt Outperform $6 → $8
Apr-12-07Reiterated Rodman & Renshaw Mkt Outperform $5 → $6
Sep-15-17 07:30AM  Repligen Announces Analyst Day and Webcast GlobeNewswire
Sep-12-17 08:02AM  See what the IHS Markit Score report has to say about Repligen Corp. Markit
Sep-08-17 07:14PM  Have Investors Already Priced In Repligen Corporations (RGEN) Growth? Simply Wall St.
Aug-30-17 03:20PM  Repligen to Present at Bairds 2017 Global Healthcare Conference GlobeNewswire
Aug-25-17 08:40AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : August 25, 2017 Capital Cube
Aug-17-17 08:01AM  See what the IHS Markit Score report has to say about Repligen Corp. Markit
Aug-14-17 06:09PM  Repligen Corp. Value Analysis (NASDAQ:RGEN) : August 14, 2017 Capital Cube
08:30AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : August 14, 2017 Capital Cube
08:01AM  See what the IHS Markit Score report has to say about Repligen Corp. Markit
Aug-13-17 04:30AM  Edited Transcript of RGEN earnings conference call or presentation 3-Aug-17 12:30pm GMT Thomson Reuters StreetEvents
Aug-03-17 06:26PM  Repligen beats Street 2Q forecasts Associated Press
10:43AM  Repligen beats Street 2Q forecasts Associated Press
07:30AM  Repligen Reports Second Quarter 2017 Financial Results GlobeNewswire
06:30AM  Investor Network: Repligen Corporation to Host Earnings Call ACCESSWIRE
Jul-31-17 10:01AM  Repligen Corp. breached its 50 day moving average in a Bearish Manner : RGEN-US : July 31, 2017 Capital Cube
Jul-27-17 07:00AM  Repligen to Report Second Quarter 2017 Financial Results GlobeNewswire
Jul-03-17 11:30AM  Top Ranked Momentum Stocks to Buy for July 3rd Zacks
Jun-27-17 07:05PM  Repligen Corporation Prices Public Offering of Shares of Common Stock GlobeNewswire
Jun-26-17 05:12PM  Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock GlobeNewswire
08:15AM  Corporate News Blog - Repligen Corp. and Spectrum Merge to Form Leader in Filtration for Bioprocessing Industry Accesswire
Jun-23-17 08:11AM  Repligen to buy filtration company Spectrum for $359 million in cash and stock MarketWatch +10.25%
07:00AM  Repligen Corporation and Spectrum, Inc. to Join Forces GlobeNewswire
Jun-20-17 11:38AM  Top 3 Healthcare Penny Stocks for 2017 Investopedia
Jun-19-17 04:03PM  ETFs with exposure to Repligen Corp. : June 19, 2017 Capital Cube
Jun-16-17 12:05PM  Repligen Corp. :RGEN-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017 Capital Cube
May-31-17 07:30AM  Repligen to Present at Jefferies 2017 Global Annual Healthcare Conference GlobeNewswire
May-24-17 07:30AM  Repligen to Participate in 14th Annual Craig-Hallum Institutional Investor Conference GlobeNewswire
May-10-17 08:50PM  Edited Transcript of RGEN earnings conference call or presentation 4-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-09-17 01:25PM  Repligen to Present at Bank of America Merrill Lynch 2017 Healthcare Conference GlobeNewswire
May-04-17 07:53AM  Repligen tops Street 1Q forecasts Associated Press +6.17%
07:30AM  Repligen Reports First Quarter 2017 Financial Results GlobeNewswire
07:15AM  Investor Network: Repligen Corporation to Host Earnings Call Accesswire
May-01-17 04:21PM  ETFs with exposure to Repligen Corp. : May 1, 2017 Capital Cube
Apr-21-17 03:04PM  ETFs with exposure to Repligen Corp. : April 21, 2017 Capital Cube
07:30AM  Repligen to Report First Quarter 2017 Financial Results GlobeNewswire
Apr-07-17 05:23PM  ETFs with exposure to Repligen Corp. : April 7, 2017 Capital Cube
Mar-17-17 03:06PM  Stocks Flat But Alphabet, Lockheed Martin Hit New Highs Investor's Business Daily
03:06PM  Stocks Flat But Alphabet, Lockheed Martin Hit New Highs
Mar-01-17 04:03PM  REPLIGEN CORP Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi
01:04PM  REPLIGEN CORP Financials
08:00AM  Top 3 Healthcare Penny Stocks for 2017 at Investopedia
Feb-23-17 12:35PM  Repligen Corp. :RGEN-US: Earnings Analysis: 2016 By the Numbers : February 23, 2017 Capital Cube
12:35PM  Repligen Corp. :RGEN-US: Earnings Analysis: 2016 By the Numbers : February 23, 2017
10:24AM  Repligen Corp. :RGEN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 23, 2017
Feb-22-17 04:31PM  Edited Transcript of RGEN earnings conference call or presentation 22-Feb-17 1:30pm GMT Thomson Reuters StreetEvents +6.04%
07:55AM  Repligen beats 4Q profit forecasts Associated Press
07:40AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:30AM  Repligen Reports Fourth Quarter 2016 Financial Results, Provides Guidance for 2017 GlobeNewswire
Feb-21-17 07:12AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : February 21, 2017 Capital Cube
07:12AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : February 21, 2017
Feb-16-17 05:02PM  Repligen To Report Fourth Quarter and Full Year 2016 Financial Results, Provides Financial Guidance for 2017 GlobeNewswire
Feb-13-17 06:37AM  Repligen upgraded by Piper Jaffray
Jan-04-17 09:30AM  The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin Pharmaceutical and Repligen Zacks
07:30AM  Repligen to Present at 35th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Jan-03-17 10:48AM  Repligen Corp. Value Analysis (NASDAQ:RGEN) : January 3, 2017
08:32AM  3 Overlooked Drug Stocks to Watch Out for in 2017
Jan-02-17 08:14AM  Repligen Corp. breached its 50 day moving average in a Bearish Manner : RGEN-US : January 2, 2017
Dec-16-16 08:15AM  Blog Coverage Repligen Acquires Maker of Tangential Flow Filtration Cassettes Accesswire
Dec-15-16 05:20PM  REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Dispositio
08:30AM  Novasep Sells U.S. Subsidiary TangenX Technology Corporation, Innovator in Tangential Flow Filtration for Biopharmaceuticals PR Newswire
07:41AM  UPDATE -- Repligen Acquires TangenX Technology Corporation GlobeNewswire
06:58AM  Repligen Acquires TangenX Technology Corporation GlobeNewswire
Dec-10-16 06:46PM  Is Repligen Corporation (RGEN) a Good Stock to Buy? at Insider Monkey
Nov-11-16 07:07AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : November 11, 2016
Nov-10-16 03:00PM  5 Health Care Stocks Set to Bounce
Nov-07-16 11:27AM  Repligen to Participate in Stephens Inc. Fall Investment Conference 2016 GlobeNewswire
Nov-03-16 02:51PM  Edited Transcript of RGEN earnings conference call or presentation 3-Nov-16 12:30pm GMT -5.67%
12:26PM  3 Important Things You Need to Know About Repligen Corporation's Q3 Results at Motley Fool
08:01AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:44AM  Repligen meets 3Q profit forecasts
07:30AM  Repligen Reports Third Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q3 2016 Repligen Corp Earnings Release - Before Market Open
Nov-01-16 10:26AM  3 Top Stocks for Risk-Averse Investors at Motley Fool
Oct-20-16 07:30AM  Repligen to Report Third Quarter 2016 Financial Results GlobeNewswire
Oct-18-16 07:30AM  Repligen Hires Ralf Kuriyel as Senior Vice President of Research & Development GlobeNewswire
Oct-13-16 10:48AM  Bedford's Ocular Therapeutix inks potential $315M deal with Regeneron at bizjournals.com
Oct-11-16 08:16AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : October 11, 2016
Oct-05-16 08:00AM  Repligen Launches Single-Use XCell ATF System for Bioprocess Intensification GlobeNewswire
Oct-04-16 10:19AM  ETFs with exposure to Repligen Corp. : October 4, 2016
Oct-03-16 12:29PM  Repligen Corp. Value Analysis (NASDAQ:RGEN) : October 3, 2016
Sep-30-16 08:27AM  Repligen Corp. breached its 50 day moving average in a Bearish Manner : RGEN-US : September 30, 2016
Sep-13-16 04:05PM  Repligen Has More Upside Ahead
Sep-02-16 04:17PM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Sep-01-16 07:30AM  Repligen to Present at Baird Global Healthcare Conference 2016 GlobeNewswire
Aug-23-16 05:07PM  These 3 Stocks Are Up Over 700% in the Last 5 Years at Motley Fool
Aug-09-16 12:07PM  Repligen Corp. :RGEN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016
Aug-04-16 04:39PM  Edited Transcript of RGEN earnings conference call or presentation 4-Aug-16 12:30pm GMT
09:59AM  Repligen beats Street 2Q forecasts
07:52AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:30AM  Repligen Reports Second Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q2 2016 Repligen Corp Earnings Release - Before Market Open
Jul-27-16 07:30AM  Repligen to Report Second Quarter 2016 Financial Results GlobeNewswire
Jul-01-16 05:23PM  Repligen Corp. Value Analysis (NASDAQ:RGEN) : July 1, 2016
Jun-30-16 08:45AM  Repligen (RGEN) in Focus: Stock Adds 6.9% in Session
08:17AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : June 30, 2016
Jun-02-16 07:30AM  Repligen to Present at Jefferies 2016 Healthcare Conference GlobeNewswire
May-31-16 08:32AM  How to Invest in the Life Cycle of a Drug at Motley Fool
May-26-16 02:52PM  Repligen to Participate in 13th Annual Craig-Hallum Institutional Investor Conference GlobeNewswire
08:20AM  3 Stocks That Help Drugmakers Create Billion Dollar Blockbusters at Motley Fool
May-24-16 04:16PM  REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Repligen Corporation, a bioprocessing company, focuses on the development, production, and commercialization of products used in the production of antibody-based therapeutics, recombinant proteins, and vaccines worldwide. It manufactures various forms of Protein A, a critical component used to purify antibody-based drugs. The company also supplies alternating tangential flow system filtration devices and protein cell culture supplements that are used in clinical and commercial stage manufacturing to enhance biologic drug yields. In addition, it manufactures and sells OPUS pre-packed chromatography columns, which are used in the purification of clinical-stage biologics; and tangential flow filtration cassettes that are used to concentrate clinical and commercial stage biologic drugs. Further, the company has a portfolio of therapeutic product candidates, which include histone deacetylase inhibitor for the treatment of Friedreich's ataxia disease; and RG1068, a synthetic human hormone developed as a novel imaging agent for the detection of pancreatic duct abnormalities in combination with magnetic resonance imaging in patients with pancreatitis and other pancreatic diseases. The company sells its bioprocessing products directly and through distributors to various life sciences companies, biopharmaceutical companies, and contract manufacturers. Repligen Corporation was founded in 1981 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAWES KAREN ADirectorMar 21Option Exercise4.2920,00085,80095,764Mar 22 05:20 PM
DAWES KAREN ADirectorMar 21Sale34.122,52186,01793,243Mar 22 05:20 PM
RYAN THOMAS F JRDirectorMar 20Option Exercise3.224,00012,88012,594Mar 22 04:34 PM
Benjamin HowardVP Business DevelopmentMar 20Option Exercise9.4414,968141,34136,124Mar 22 04:41 PM
Benjamin HowardVP Business DevelopmentMar 20Sale34.6212,216422,95423,908Mar 22 04:41 PM
RYAN THOMAS F JRDirectorMar 20Sale34.834,000139,3218,594Mar 22 04:34 PM
Snodgres JonChief Financial OfficerMar 17Option Exercise24.504,00098,00027,789Mar 21 09:03 PM
Snodgres JonChief Financial OfficerMar 17Sale34.911,90966,64623,789Mar 21 09:03 PM
Hunt AnthonyChief Executive OfficerNov 28Sale33.125,000165,61368,342Nov 29 04:58 PM